178 related articles for article (PubMed ID: 9930301)
1. Gene transfer vectors derived from equine infectious anemia virus.
Olsen JC
Gene Ther; 1998 Nov; 5(11):1481-7. PubMed ID: 9930301
[TBL] [Abstract][Full Text] [Related]
2. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
[TBL] [Abstract][Full Text] [Related]
3. Optimization of equine infectious anemia derived vectors for hematopoietic cell lineage gene transfer.
O'Rourke JP; Olsen JC; Bunnell BA
Gene Ther; 2005 Jan; 12(1):22-9. PubMed ID: 15550928
[TBL] [Abstract][Full Text] [Related]
4. A replication competent lentivirus (RCL) assay for equine infectious anaemia virus (EIAV)-based lentiviral vectors.
Miskin J; Chipchase D; Rohll J; Beard G; Wardell T; Angell D; Roehl H; Jolly D; Kingsman S; Mitrophanous K
Gene Ther; 2006 Feb; 13(3):196-205. PubMed ID: 16208418
[TBL] [Abstract][Full Text] [Related]
5. Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cells.
Siapati EK; Bigger BW; Miskin J; Chipchase D; Parsley KL; Mitrophanous K; Themis M; Thrasher AJ; Bonnet D
Mol Ther; 2005 Sep; 12(3):537-46. PubMed ID: 16099415
[TBL] [Abstract][Full Text] [Related]
6. Trophic activity of Rabies G protein-pseudotyped equine infectious anemia viral vector mediated IGF-I motor neuron gene transfer in vitro.
Teng Q; Garrity-Moses M; Federici T; Tanase D; Liu JK; Mazarakis ND; Azzouz M; Walmsley LE; Carlton E; Boulis NM
Neurobiol Dis; 2005 Dec; 20(3):694-700. PubMed ID: 16005636
[TBL] [Abstract][Full Text] [Related]
7. Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors.
McKay T; Patel M; Pickles RJ; Johnson LG; Olsen JC
Gene Ther; 2006 Apr; 13(8):715-24. PubMed ID: 16397505
[TBL] [Abstract][Full Text] [Related]
8. Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectors.
Balaggan KS; Binley K; Esapa M; Iqball S; Askham Z; Kan O; Tschernutter M; Bainbridge JW; Naylor S; Ali RR
J Gene Med; 2006 Mar; 8(3):275-85. PubMed ID: 16299834
[TBL] [Abstract][Full Text] [Related]
9. In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies.
Lamikanra A; Myers KA; Ferris N; Mitrophanous KA; Carroll MW
Gene Ther; 2005 Jun; 12(12):988-98. PubMed ID: 15772687
[TBL] [Abstract][Full Text] [Related]
10. Gene transduction efficiency in cells of different species by HIV and EIAV vectors.
Ikeda Y; Collins MK; Radcliffe PA; Mitrophanous KA; Takeuchi Y
Gene Ther; 2002 Jul; 9(14):932-8. PubMed ID: 12085241
[TBL] [Abstract][Full Text] [Related]
11. Stable gene transfer to the nervous system using a non-primate lentiviral vector.
Mitrophanous K; Yoon S; Rohll J; Patil D; Wilkes F; Kim V; Kingsman S; Kingsman A; Mazarakis N
Gene Ther; 1999 Nov; 6(11):1808-18. PubMed ID: 10602376
[TBL] [Abstract][Full Text] [Related]
12. Both HIV- and EIAV-based lentiviral vectors mediate gene delivery to pancreatic cancer cells and human pancreatic primary patient xenografts.
Saraga G; Mafficini A; Ghaneh P; Sorio C; Costello E
Cancer Gene Ther; 2007 Sep; 14(9):781-90. PubMed ID: 17571071
[TBL] [Abstract][Full Text] [Related]
13. The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs.
Mergia A; Chari S; Kolson DL; Goodenow MM; Ciccarone T
Virology; 2001 Feb; 280(2):243-52. PubMed ID: 11162838
[TBL] [Abstract][Full Text] [Related]
14. Development of inducible EIAV-based lentiviral vector packaging and producer cell lines.
Stewart HJ; Leroux-Carlucci MA; Sion CJ; Mitrophanous KA; Radcliffe PA
Gene Ther; 2009 Jun; 16(6):805-14. PubMed ID: 19262613
[TBL] [Abstract][Full Text] [Related]
15. The integration profile of EIAV-based vectors.
Hacker CV; Vink CA; Wardell TW; Lee S; Treasure P; Kingsman SM; Mitrophanous KA; Miskin JE
Mol Ther; 2006 Oct; 14(4):536-45. PubMed ID: 16950499
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
Zhang J; Frolov I; Russell SJ
J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
[TBL] [Abstract][Full Text] [Related]
17. Development of photoreceptor-specific promoters and their utility to investigate EIAV lentiviral vector mediated gene transfer to photoreceptors.
Nicoud M; Kong J; Iqball S; Kan O; Naylor S; Gouras P; Allikmets R; Binley K
J Gene Med; 2007 Dec; 9(12):1015-23. PubMed ID: 17963276
[TBL] [Abstract][Full Text] [Related]
18. Comparison of gene transfer efficiencies and gene expression levels achieved with equine infectious anemia virus- and human immunodeficiency virus type 1-derived lentivirus vectors.
O'Rourke JP; Newbound GC; Kohn DB; Olsen JC; Bunnell BA
J Virol; 2002 Feb; 76(3):1510-5. PubMed ID: 11773424
[TBL] [Abstract][Full Text] [Related]
19. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.
Blesch A
Methods; 2004 Jun; 33(2):164-72. PubMed ID: 15121171
[TBL] [Abstract][Full Text] [Related]
20. Surface-engineering of lentiviral vectors.
Verhoeyen E; Cosset FL
J Gene Med; 2004 Feb; 6 Suppl 1():S83-94. PubMed ID: 14978753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
